HR-positive/HER2-negative is the most common subtype of breast cancer in women. HR-positive/HER2-negative metastatic breast cancer is distinct in its response to hormone therapies due to the presence ...

DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...

HR+/HER2- breast cancer occurs when cells in the breast tissue mutate and grow uncontrollably. Researchers aren't certain what causes breast cancer but have determined several risk factors.

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

HER2-negative means the cancer cells lack, or have very low levels of, the HER2 protein. HER-2-low breast cancer is a subset within HER2-negative disease, ...

HER2, short for human epidermal growth factor receptor 2, describes a protein that plays a role in normal breast cell development. But in some breast cancers, the HER2 gene produces too many proteins.

A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

Human epidermal growth factor receptor 2 (HER2) is a protein that helps breast cancer cells grow quickly. Breast cancer cells with higher than normal levels of HER2 are called HER2-positive.

Olivia Munn is opening up about her mom's breast cancer diagnosis. The "Your Friends and Neighbors" star, 45, took to ...

The research team engrafted the mice with murine lung cancer cells that were transduced with the ectodomain of mHER2, for high expression of HER2. Using this model, Basel found that “the development ...